Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy

Author： Yokota Toshifumi Pistilli Emidio Duddy William Nagaraju Kanneboyina

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.7, Iss.6, 2007-06, pp. : 831-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing Effective Therapy for Duchenne Muscular Dystrophy (DMD): Challenges and Promises

Current Chemical Biology, Vol. 8, Iss. 3, 2014-01 ,pp. : 117-131

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Disruption of Exon 52 in the Mouse Dystrophin Gene Induced Muscle Degeneration Similar to That Observed in Duchenne Muscular Dystrophy

By Araki E. Nakamura K. Nakao K. Kameya S. Kobayashi O. Nonaka I. Kobayashi T. Katsuki M.

Biochemical and Biophysical Research Communications, Vol. 238, Iss. 2, 1997-09 ,pp. : 492-497

Elsevier

Access to resources Recommend Favorite

Stem cell therapy for muscular dystrophy

By Sohn Regina Lee Gussoni Emanuela

Expert Opinion on Biological Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-9

Informa Healthcare

Access to resources Recommend Favorite

Early Decrease of IIx Myosin Heavy Chain Transcripts in Duchenne Muscular Dystrophy

By Pedemonte M. Sandri C. Schiaffino S. Minetti C.

Biochemical and Biophysical Research Communications, Vol. 255, Iss. 2, 1999-02 ,pp. : 466-469

Elsevier

Access to resources Recommend Favorite

Increased Number of Caveolae and Caveolin-3 Overexpression in Duchenne Muscular Dystrophy

By Repetto S. Bado M. Broda P. Lucania G. Masetti E. Sotgia F. Carbone I. Pavan A. Bonilla E. Cordone G. Lisanti M.P. Minetti C.

Biochemical and Biophysical Research Communications, Vol. 261, Iss. 3, 1999-08 ,pp. : 547-550

Elsevier

Access to resources Recommend Favorite